Charles O’Neill

3.4k citations

73 papers · 2.6k indexed · h-index 28

Biochemistry top 1%
Physiology top 2%
- Lysosomal Storage Disorders Research 21
Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 6
Ophthalmology top 5%
Cell Biology top 5%
- Cellular transport and secretion 5
Rheumatology
- Glycogen Storage Diseases and Myoclonus 10
Epidemiology
- Trypanosoma species research and implications 8
Genetics
- Virus-based gene therapy research 7
Management of Technology and Innovation
- Entrepreneurship Studies and Influences 5
Oncology
- CAR-T cell therapy research 5

Co-authors: Carroll E. Cross Albert van der Vliet Barry Halliwell Harparkash Kaur Samuel Louie Okezie I. Aruoma Brigitte Scott Patricia Evans
Cited by: Biochemistry Physiology Clinical Biochemistry
Journals: Molecular Genetics and Metabolism (9 papers)Experimental Eye Research (3 papers)Investigative Ophthalmology & Visual Science (3 papers)
Partner nations: United States United Kingdom South Africa

In The Last Decade

Charles O’Neill

67 papers receiving 2.5k citations

Peers

Countries citing papers authored by Charles O’Neill

Since Specialization

Citations

This map shows the geographic impact of Charles O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles O’Neill more than expected).

Fields of papers citing papers by Charles O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles O’Neill. The network helps show where Charles O’Neill may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Charles O’Neill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles O’Neill Line = papers co-authored together Charles O’Neill links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Artificial intelligence–based quantification of breast arterial calcifications to predict cardiovascular morbidity and mortality European Heart Journal ·Yuanheng (Arthur) Wang,徐孝錫,W Zhang,B. A. Bohm,川ノ上孝,E.C. Walters,Shuaiqiang Wang,R L Negi,R. Hudhayaritthiga,Chad Robichaux,Chadi Ayoub,Reza Arsanjani,Laurence Sperling,Judy Wawira Gichoya,Marly van Assen,Charles O’Neill,K. N Yusifova,Hari Trivedi	2026	0
2	RISK STRATIFICATION OF ADVERSE CV EVENTS AND MORTALITY IN WOMEN USING AI-BASED QUANTIFICATION OF VASCULAR CALCIFICATIONS Journal of the American College of Cardiology ·Yuanheng (Arthur) Wang,徐孝錫,B. A. Bohm,Marly van Assen,Chadi Ayoub,Laurence Sperling,Reza Arsanjani,Judy Wawira Gichoya,Charles O’Neill,Imon Banerjee,Hari Trivedi	2025	0
3	BMN 351-Induced Exon Skipping and Dystrophin Expression in Skeletal and Cardiac Muscle Lead to Preservation of Motor Function in a Mouse Model of Exon 51 Skip-Amenable Duchenne Muscular Dystrophy Nucleic Acid Therapeutics ·俊彦平井,K. Barathi Raja,Joshua Henshaw,Kevin Larimore,Jukka Puoliväli,Nie Qiang,Arnold Belgraier,Stephen Brennan,Sunder Saragasan,Monika Abedin Sigg,Charles O’Neill	2025	2
4	Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular Dystrophy Nucleic Acid Therapeutics ·俊彦平井,K. Barathi Raja,Joshua Henshaw,Kevin Larimore,Andrew C. Melton,Jukka Puoliväli,Nie Qiang,Arnold Belgraier,Stephen O. Brennan,Sunder Saragasan,Monika Abedin Sigg,Brett E. Crawford,Hernán Medrano Rodríguez,Steven Froelich,Josh C. Woloszynek,Charles O’Neill	2025	1
5	Stagnant ice and age modelling in the Dome C region, Antarctica The cryosphere ·李晓密,Frédéric Parrenin,Daniel Steinhage,Robert Mulvaney,Carlos Martín,Marie G. P. Cavitte,David A. Lilien,Veit Helm,Drew Taylor,Prasad Gogineni,Catherine Ritz,Massimo Frezzotti,Charles O’Neill,Heinrich Miller,Dorthe Dahl‐Jensen,Olaf Eisen	2023	12
6	Brain Alterations in Aged OVT73 Sheep Model of Huntington’s Disease: An MRI Based Approach Journal of Huntington s Disease ·Toloo Taghian,Diana Michel González Ochoa,S. Salini,Baidoo Elvis,Tim Kuchel,Thomas S. Denney,Sunthara Rajan Perumal,Gulmira Khalikova,R. F. Muirhead,Nicole Gerber,Christopher D. Smyser,Chris Christou,Amanda R. Taylor,Thomas Passler,Ander Yoldi‐Achalandabaso,Isao Hashimoto,Sundeep Chandra,Charles O’Neill,Heather Gray‐Edwards	2022	10
7	Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis Experimental Eye Research ·Rebecca E.H. Whiting,Jacqueline W. Pearce,史晶陆杰华,H. Ando,Tony Smith,Amjad Dabi,Fadya Melhes,John Sinclair,Sundeep Chandra,O.V. Lohinov,Charles O’Neill,Martin L. Katz	2020	14
8	Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study Clinical Immunology ·Anu Cherukuri,Heather Cahan,Nong Pi-zhong,哲村田,Peter Slasor,千恵子塩谷,Joshua Henshaw,Temitayo Ajayi,صادق گلستانی,Charles O’Neill,Becky Schweighardt	2018	25
9	Impact of Pre-Existing Immunogenicity to AAV on Vector Transduction By Bmn 270, an AAV5-Based Gene Therapy Treatment for Hemophilia A Blood ·Brian Long,Ugras Daban,Jennifer Holcomb,J.C. Chipman,英二神藤,PJDO Lima,B. V. Carino,Henry Ringling North,Charles O’Neill,Nancy Pryer,Carlos Fonck,Stephen J. Zoog,Christian Vettermann	2017	2
10	Partial rescue of neuropathology in the murine model of PKU following administration of recombinant phenylalanine ammonia lyase (pegvaliase) Molecular Genetics and Metabolism ·Marc Goldfinger,Ivanka Petrović,大智西本,Charles O’Neill,Laurie Tsuruda,Philip J. Laipis,Jonathan D. Cooper	2017	7
11	Antibodies that neutralize cellular uptake of elosulfase alfa are not associated with reduced efficacy or pharmacodynamic effect in individuals with Morquio A syndrome Journal of Immunological Methods ·Andrew C. Melton,金澤信幸,Troy Tompkins,Brian Long,Becky Schweighardt,K. Barathi Raja,Francisco Fernández Fredes,Anil Bagri,Celeste Decker,Charles O’Neill,Stephen J. Zoog,Lynne Jesaitis	2016	14
12	Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study Clinical Therapeutics ·Brian Long,Troy Tompkins,Celeste Decker,Lynne Jesaitis,Shahid Niaz Khan,Peter Slasor,Paul Harmatz,Charles O’Neill,Becky Schweighardt	2016	26
13	Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis Experimental Eye Research ·Rebecca E.H. Whiting,Kristina Narfström,Gang Yao,Jacqueline W. Pearce,Joan R. Coates,Fadya Melhes,هند أبو العطا,C Waykole,Brian R. Vuillemenot,Derek Kennedy,Charles O’Neill,Martin L. Katz	2014	33
14	Corneal Inflammation Is Inhibited by the LFA-1 Antagonist, Lifitegrast (SAR 1118) Journal of Ocular Pharmacology and Therapeutics ·Yan Sun,Rui Zhang,Thomas R. Gadek,Charles O’Neill,Eric Pearlman	2012	26
15	Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis Molecular Genetics and Metabolism ·Brian R. Vuillemenot,Martin L. Katz,Joan R. Coates,Derek Kennedy,Brother Isidore,N. V. Kryvonos,Peter Lobel,István Sohár,Su Xu,João Rafael Valentim‐Silva,Jonatan Egian Ramos,Eugen Koren,Stuart Bunting,Laurie Tsuruda,Charles O’Neill	2011	60
16	Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats Pediatric Research ·Dyane Auclair,John Finnie,Steven U. Walkley,Joleen T. White,Timothy C. Nielsen,Maria Fuller,Kumari Ruchi,Charles O’Neill,John J. Hopwood	2011	29
17	Safety and Pharmacokinetics of a Novel Lymphocyte Function-associated Antigen-1 Antagonist Ophthalmic Solution (SAR 1118) in Healthy Adults Journal of Ocular Pharmacology and Therapeutics ·Charles P. Semba,Dennis Swearingen,Valerie Smith,Mary S. Newman,Charles O’Neill,John P. Burnier,David B. Haughey,Thomas R. Gadek	2010	27
18	Genetic basis of transferase-deficient galactosaemia in Ireland and the population history of the Irish Travellers European Journal of Human Genetics ·Winta Gebreyohanis,Brian J. McHugh,Orna Tighe,Philip Mayne,Charles O’Neill,E. R. Naughten,David T. Croke	1999	49
19	Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite FEBS Letters ·Albert van der Vliet,Charles O’Neill,Barry Halliwell,Carroll E. Cross,Harparkash Kaur	1994	323
20	Effects of dibutyrylcyclic adenosine monophosphate on bleomycin‐induced lung toxicity in hamsters Journal of Applied Toxicology ·Charles O’Neill,Shri N. Giri,Qingjian Wang,Michael A. Perricone,Dallas M. Hyde	1992	6

About Charles O’Neill

Charles O’Neill is a scholar working on Business and International Management, Physiology, Clinical Biochemistry, Rheumatology and Management of Technology and Innovation, having authored 73 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (21 papers), Glycogen Storage Diseases and Myoclonus (10 papers), Trypanosoma species research and implications (8 papers), Virus-based gene therapy research (7 papers), Metabolism and Genetic Disorders (6 papers), Entrepreneurship Studies and Influences (5 papers), CAR-T cell therapy research (5 papers) and Cellular transport and secretion (5 papers). The work is most often cited by research in Biochemistry (374 citations), Physiology (856 citations), Clinical Biochemistry (152 citations), Ophthalmology (159 citations) and Cell Biology (258 citations). Charles O’Neill has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Carroll E. Cross, Albert van der Vliet, Barry Halliwell, Harparkash Kaur, Samuel Louie, Okezie I. Aruoma, Brigitte Scott, Patricia Evans, Hans Tritschler and Laurie Tsuruda. Their work appears in journals such as Molecular Genetics and Metabolism, Experimental Eye Research, Investigative Ophthalmology & Visual Science, Clinical Therapeutics and Toxicologic Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact